TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9060016

Group type: EXPERIMENTAL
Intervention: Phentolamine (alpha‐adrenoreceptor antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 8484505

Group type: EXPERIMENTAL
Intervention: 15 micrograms/kg alfentanil (A15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 30 micrograms/kg alfentanil (A30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 45 micrograms/kg alfentanil (A45)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 60
Study: 3625846

Group type: EXPERIMENTAL
Intervention: Chlorhexidine irrigation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no chlorhexidine irrigation)
Number of subjects: 100
Study: 29437574

Group type: EXPERIMENTAL
Intervention: CSL112 (apolipoprotein A-I [human])
Number of subjects: 0
Study: 28145396

Group type: EXPERIMENTAL
Intervention: Actimove sling
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Shoulderlift sling
Number of subjects: 28

Group type: COMPARATOR
Intervention: No sling (control group)
Number of subjects: 28
Study: 25933364

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 97
Study: 23819667

Group type: EXPERIMENTAL
Intervention: Personalized in-home nursing care plan
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard care at mental health center
Number of subjects: 94
Study: 21597232

Group type: EXPERIMENTAL
Intervention: Bright light exposure for 10 minutes on workday mornings
Number of subjects: 61

Group type: COMPARATOR
Intervention: Non-BL periods
Number of subjects: 61
Study: 17917935

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream, 8 weeks of treatment with once‐daily dosing for alternate weeks (R1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream, 5 weeks of once‐daily dosing with a 1‐week interval (R2)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Composite median visual analogue scores at week 8
Number of subjects: 32
Study: 17313005

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture
Number of subjects: 95

Group type: COMPARATOR
Intervention: Diltiazem (oral administration)
Number of subjects: 95
Study: 15297112

Group type: EXPERIMENTAL
Intervention: Preoperative oral carbohydrate treatment (12.5%, 800 + 400 ml, n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 14
Study: 10642712

Group type: EXPERIMENTAL
Intervention: Bypass grafting surgery
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 526

Group type: COMPARATOR
Intervention: Medical management (unmatched patients)
Number of subjects: 526

Group type: COMPARATOR
Intervention: Medical management (matched patients)
Number of subjects: 526
Study: 9309461

Group type: EXPERIMENTAL
Intervention: Personalized approach to controlled ovarian hyperstimulation (COH) based on BMI and WHR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional protocol for controlled ovarian hyperstimulation (COH)
Number of subjects: 0
Study: 8157045

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Terbutaline slow-release 7.5 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 3565935

Group type: EXPERIMENTAL
Intervention: Almitrine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31657168

Group type: EXPERIMENTAL
Intervention: PGLA thread-embedding therapy combined with rehabilitation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 60
Study: 28343601

Group type: EXPERIMENTAL
Intervention: RG7652 (1 of 5 doses)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: RG7652
Number of subjects: 248

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study: 26489661

Group type: EXPERIMENTAL
Intervention: specialised Helping Young People Early service model plus up to 16 sessions of individual cognitive analytic therapy
Number of subjects: 135

Group type: COMPARATOR
Intervention: Helping Young People Early service plus up to 16 sessions of a control psychotherapy condition known as 'befriending'
Number of subjects: 135

Group type: COMPARATOR
Intervention: a general youth mental health care model plus up to 16 sessions of befriending
Number of subjects: 135
Study: 24188276

Group type: EXPERIMENTAL
Intervention: Comprehensive traditional Chinese medicine rehabilitation protocol
Number of subjects: 722

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 722
Study: 21347988

Group type: EXPERIMENTAL
Intervention: Fast presentation rates (auditory ISL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow presentation rates (visual ISL)
Number of subjects: 0
Study: 19422296

Group type: EXPERIMENTAL
Intervention: AdoMet (800 mg per day) for 4 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 17174632

Group type: EXPERIMENTAL
Intervention: Opinion leader intervention (patient-specific one-page evidence summaries)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Opinion leader intervention (in HF subgroup)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care (HF subgroup control)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Opinion leader intervention (in IHD subgroup)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Usual care (IHD subgroup control)
Number of subjects: 171
Study: 14977622

Group type: EXPERIMENTAL
Intervention: Inhaled furosemide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 11731184

Group type: EXPERIMENTAL
Intervention: Calcitonin and 1 alpha-hydroxycholecalciferol combination
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Calcitonin alone
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: 1 alpha-hydroxycholecalciferol alone
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Combination regimen
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Calcitonin treatment
Number of subjects: 202
Study: 9789699

Group type: EXPERIMENTAL
Intervention: Procainamide (100 mg i.v. bolus every 5 min up to 1 g)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Propafenone (2 mg/kg body weight i.v. over 30 min)
Number of subjects: 117
Study: 7633974

Group type: EXPERIMENTAL
Intervention: Dopamine 3 micrograms/kg/min
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2585215

Group type: EXPERIMENTAL
Intervention: Vitamin K1 (5 mg intramuscularly)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no vitamin K1)
Number of subjects: 14
Study: 793777

Group type: EXPERIMENTAL
Intervention: 150 mg amitriptyline as 3 daytime doses
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 150 mg amitriptyline as a single dose at bedtime
Number of subjects: 41
Study: 31105976

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN)
Number of subjects: 2023

Group type: COMPARATOR
Intervention: No GTN
Number of subjects: 2023

Group type: EXPERIMENTAL
Intervention: Continuing prestroke antihypertensives
Number of subjects: 2023

Group type: COMPARATOR
Intervention: Stopping prestroke antihypertensives
Number of subjects: 2023
Study: 28809637

Group type: EXPERIMENTAL
Intervention: Operative treatment using plate osteosynthesis (LCP Distal Ulna Plate) for proximal third ulnar styloid process fractures, ulnar head fractures, and subcapital fractures.
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Conservative treatment for tip fractures of ulnar styloid process.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conservative treatment for ulnar base fractures.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Operative treatment for subcapital ulnar fractures.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conservative treatment for ulnar head fractures.
Number of subjects: 81
Study: 25661658

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24529671

Group type: EXPERIMENTAL
Intervention: bupivacaine 10 mg combined with 0.1 mg/kg ketamine
Number of subjects: 60

Group type: COMPARATOR
Intervention: bupivacaine 10 mg combined with 0.5 mL distilled water
Number of subjects: 60
Study: 21492183

Group type: EXPERIMENTAL
Intervention: Single platelet units (SPUs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Double platelet units (DPUs)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Storage of PBMCs in autologous plasma in PVC‐bags at room temperature
Number of subjects: 18
Study: 19321651

Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18005303

Group type: EXPERIMENTAL
Intervention: Systematic searching of the Polish Medical Bibliography
Number of subjects: 680
Study: 15554471

Group type: EXPERIMENTAL
Intervention: Guided imagery audio tape intervention
Number of subjects: 13

Group type: COMPARATOR
Intervention: Usual care and a music audio tape
Number of subjects: 13
Study: 11207083

Group type: EXPERIMENTAL
Intervention: Dynamic analysis of the QT interval
Number of subjects: 0
Study: 9444592

Group type: EXPERIMENTAL
Intervention: Full-strength oxidizing lozenge
Number of subjects: 123

Group type: COMPARATOR
Intervention: Breath mints
Number of subjects: 123

Group type: COMPARATOR
Intervention: Chewing gum with no active ingredients
Number of subjects: 123

Group type: COMPARATOR
Intervention: Regular oxidizing lozenge
Number of subjects: 123

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 123
Study: 7920310

Group type: EXPERIMENTAL
Intervention: ganciclovir
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: foscarnet
Number of subjects: 25
Study: 3284282

Group type: EXPERIMENTAL
Intervention: Contingency contracting for medication take-home privileges
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Contingency contracting targeting non-cocaine drugs
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Non-drug-related contracts
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Contingency contracting
Number of subjects: 40
Study: 31465756

Group type: EXPERIMENTAL
Intervention: Exercise therapy plus dry needling (Ex+DN group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Exercise therapy (Ex group)
Number of subjects: 40
Study: 31242937

Group type: EXPERIMENTAL
Intervention: CIPEXERCISE (hand exercise program)
Number of subjects: 55

Group type: COMPARATOR
Intervention: CIPCONTROL (compensatory intervention only)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: CIPEXERCISE
Number of subjects: 55

Group type: COMPARATOR
Intervention: CIPCONTROL
Number of subjects: 55
Study: 27334604

Group type: EXPERIMENTAL
Intervention: Topical anesthesia (group 1, n=76)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia (group 2, n=81)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Overall pain and discomfort scores
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Surgeon comfort scores
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Additional anesthesia or sedation
Number of subjects: 157
Study: 26059102

Group type: EXPERIMENTAL
Intervention: Methanocalculus‐specific TaqMan qPCR assay
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formate as the substrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Field application of the qPCR assay
Number of subjects: 0
Study: 23274148

Group type: EXPERIMENTAL
Intervention: SBS-QoL™ scale
Number of subjects: 0
Study: 21611981

Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil 1200 mg once daily
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 18465136

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 62

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 62
Study: 17380212

Group type: EXPERIMENTAL
Intervention: Mecasermin rinfabate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unbound recombinant human IGF‐I (rhIGF‐I)
Number of subjects: 0
Study: 15159270

Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (1500/20 mg)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (2000/40 mg)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: niacin ER (each 500 mg increase)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: niacin ER/lovastatin (2000/40 mg/d)
Number of subjects: 164
Study: 11684748

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 157

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 157

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 157

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 157
Study: 9737476

Group type: EXPERIMENTAL
Intervention: Enoxaparin (1 mg/kg twice daily subcutaneously)
Number of subjects: 3171

Group type: COMPARATOR
Intervention: Unfractionated heparin (continuous intravenous)
Number of subjects: 3171
Study: 7887165

Group type: EXPERIMENTAL
Intervention: Local specific immunotherapy plus sodium cromoglycate
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sodium cromoglycate and saline solution
Number of subjects: 40
Study: 3580432

Group type: EXPERIMENTAL
Intervention: 1.5 mg RS 86
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3.0 mg RS 86
Number of subjects: 12
Study: 30875669

Group type: EXPERIMENTAL
Intervention: NEW Tx (Nutrition Exercise and Wellness Treatment)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (treatment as usual waitlist)
Number of subjects: 38
Study: 28527047

Group type: EXPERIMENTAL
Intervention: Dietary ascorbic acid (50 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary ascorbic acid (100 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (1.30% effluent without ascorbic acid)
Number of subjects: 0
Study: 26923336

Group type: EXPERIMENTAL
Intervention: High serum levels of DHEAS (highest tertile) in males
Number of subjects: 1258

Group type: COMPARATOR
Intervention: Lower serum levels of DHEAS (reference group) in males
Number of subjects: 1258

Group type: EXPERIMENTAL
Intervention: High serum levels of DHEAS (highest tertile) in females
Number of subjects: 1258

Group type: COMPARATOR
Intervention: Lower serum levels of DHEAS (reference group) in females
Number of subjects: 1258
Study: 24615602

Group type: EXPERIMENTAL
Intervention: Minimally invasive video-assisted thyroidectomy (MIVAT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Robot-assisted transaxillary thyroidectomy (RATT)
Number of subjects: 62
Study: 22248536

Group type: EXPERIMENTAL
Intervention: Low-load condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-load condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Valid trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High perceptual load condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Invalid trials
Number of subjects: 0
Study: 18562788

Group type: EXPERIMENTAL
Intervention: Multicomponent training (2 sessions per week for 8 months)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Detraining (3 months after training)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study: 17335363

Group type: EXPERIMENTAL
Intervention: Bioactive ceramic filler
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (open debridement alone)
Number of subjects: 19
Study: 15593456

Group type: EXPERIMENTAL
Intervention: Pylorus-preserving gastrectomy (PPG)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional distal gastrectomy (CDG)
Number of subjects: 81
Study: 11449084

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Untreated women
Number of subjects: 116
Study: 9544237

Group type: EXPERIMENTAL
Intervention: Intravenous gamma globulin (IVIG) therapy
Number of subjects: 7

Group type: COMPARATOR
Intervention: Matched pediatric control patients (PCC)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Parents of KD patients
Number of subjects: 7
Study: 7541325

Group type: EXPERIMENTAL
Intervention: rhG-CSF (Granulocyte Injection) with chemotherapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 22
Study: 2905239

Group type: EXPERIMENTAL
Intervention: Roxatidine acetate 75 mg twice daily
Number of subjects: 700

Group type: COMPARATOR
Intervention: Cimetidine 200 mg four times daily
Number of subjects: 700
Study: 31771895

Group type: EXPERIMENTAL
Intervention: Prostate Artery Embolization (PAE)
Number of subjects: 0
Study: 30239116

Group type: EXPERIMENTAL
Intervention: Immediate exercise (IMEX, n=54)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Delayed exercise (DEL, n=50)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Immediate exercise (IMEX)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Delayed exercise (DEL)
Number of subjects: 104
Study: 27243350

Group type: EXPERIMENTAL
Intervention: ACUVUE OASYS for Presbyopia
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: AIR OPTIX AQUA Multifocal
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Initial fitting
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Acuity-based measures
Number of subjects: 55
Study: 25886844

Group type: EXPERIMENTAL
Intervention: HIRT HEMS
Number of subjects: 505

Group type: COMPARATOR
Intervention: GSA HEMS
Number of subjects: 505
Study: 24011382

Group type: EXPERIMENTAL
Intervention: Induction of labour (IOL)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Expectant monitoring (EM)
Number of subjects: 201
Study: 21383109

Group type: EXPERIMENTAL
Intervention: Cognitive strategy instruction based on PASS for 10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard math instruction (Control)
Number of subjects: 0
Study: 19286143

Group type: COMPARATOR
Intervention: Burch colposuspension
Number of subjects: 655

Group type: COMPARATOR
Intervention: Sling surgery
Number of subjects: 655

Group type: EXPERIMENTAL
Intervention: Successful surgery
Number of subjects: 655

Group type: COMPARATOR
Intervention: Incontinence
Number of subjects: 655

Group type: COMPARATOR
Intervention: Fear of incontinence
Number of subjects: 655

Group type: COMPARATOR
Intervention: Vaginal bulging
Number of subjects: 655

Group type: COMPARATOR
Intervention: Negative emotional reactions during sex
Number of subjects: 655
Study: 17407633

Group type: EXPERIMENTAL
Intervention: EZE + ATV (Ezetimibe 10 mg + Atorvastatin 10 mg)
Number of subjects: 148

Group type: COMPARATOR
Intervention: ATV (Atorvastatin 10 mg)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: EZE + ATV
Number of subjects: 148

Group type: COMPARATOR
Intervention: ATV
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: EZE + ATV and ATV
Number of subjects: 148
Study: 15351413

Group type: EXPERIMENTAL
Intervention: St. Georg Sled (fixed bearing UKR)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Oxford mobile bearing UKR
Number of subjects: 91
Study: 11095203

Group type: EXPERIMENTAL
Intervention: Glycolic acid peels (20%, 35%, 50%, and 70% concentrations) applied serially at 2-week intervals to 23 patients in Group A
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: 15% glycolic acid cream used once or twice daily for 24 weeks by 20 patients in Group B
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo cream applied twice daily for 24 weeks by 15 patients in Group C
Number of subjects: 58
Study: 9506004

Group type: EXPERIMENTAL
Intervention: Theophylline (5 mg/kg anhydrous, oral administration)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Theophylline and Placebo
Number of subjects: 7
Study: 8456071

Group type: EXPERIMENTAL
Intervention: Fast-disintegrating vitamin C tablet (8-9 min)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Vitamin C tablet with a mean disintegration time of 60 min
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard vitamin C solution
Number of subjects: 15
Study: 2416520

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (1 g/day) for four weeks (standard treatment group)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment (1 g/day) for a minimum of one week and thereafter until symptoms controlled (symptomatic treatment group)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Both treatment regimens (standard and symptomatic)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Symptomatic treatment group
Number of subjects: 75

Group type: COMPARATOR
Intervention: Patients with unhealed ulcers
Number of subjects: 75
Study: 31033669

Group type: EXPERIMENTAL
Intervention: Professional experience in the prevention and control of HIV, other sexually transmitted infections, or other infectious diseases
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Working at MMT clinics affiliated with Center for Disease Control and Prevention sites
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Perception of greater institutional support
Number of subjects: 76
Study: 28922046

Group type: EXPERIMENTAL
Intervention: Supraorbital electrical stimulation (SOES) in addition to conventional physical therapy (20 minutes daily for 8 weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Conventional physical therapy (3 times a week for 8 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Prescribed medications only
Number of subjects: 45
Study: 26271817

Group type: EXPERIMENTAL
Intervention: History of childhood sexual and/or physical abuse (CSA and/or CPA) among men
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: History of childhood sexual and/or physical abuse (CSA and/or CPA) among women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participants with histories of CSA and/or CPA
Number of subjects: 0
Study: 25083090

Group type: EXPERIMENTAL
Intervention: Biofeedback-guided pelvic floor exercise therapy (BFT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Oral polyethylene glycol (PEG)
Number of subjects: 88
Study: 22137497

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (300 μg daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 51